Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28704394 | 0.96 | GPR84 (0.48) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL17219357 | 0.94 | GPR84 (0.47) | GPR84FFAR1ZDHHC7 | |
| SCHEMBL29697233 | 0.93 | GPR84 (0.57) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL3312860 | 0.93 | GPR84 (0.57) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL30778412 | 0.93 | GPR84 (0.57) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL223182 | 0.93 | GPR84 (0.57) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL29924279 | 0.91 | GPR84 (0.46) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL28687233 | 0.91 | GPR84 (0.46) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL27595001 | 0.91 | GPR84 (0.55) | GPR84FFAR1ZDHHC7FAAH | |
| SCHEMBL116891 | 0.88 | PRKCA (0.43) | GPR84FFAR1ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| WO-2025242863-A1 | DISCOLORING COMPOSITION FOR KERATIN FIBERS DYED WITH OXIDATIVE DYES OR DIRECT DYES | KAO CORPORATION (JP) | 2025-11-27 | — | — | WO | claimed |
| WO-2025242867-A1 | DISCOLORING COMPOSITION FOR KERATIN FIBERS DYED WITH OXIDATIVE DYES OR DIRECT DYES | KAO CORPORATION (JP) | 2025-11-27 | — | — | WO | claimed |
| US-20250235435-A1 | INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST | ARCUTIS BIOTHERAPEUTICS, INC. (US) | 2025-07-24 | — | — | US | claimed |
| EP-4578511-A1 | LIQUID OILY COMPOSITION, AND COSMETIC MATERIAL CONTAINING LIQUID OILY COMPOSITION | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2025-07-02 | — | — | EP | claimed |
| US-12336983-B2 | Inhibition of crystal growth of roflumilast | ARCUTIS BIOTHERAPEUTICS, INC. (US) | 2025-06-24 | — | — | US | claimed |
| CN-120154562-A | Composition with full-band invisible light blocking and sun screening effects and application thereof | 广州海龟爸爸生物科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| US-20250170047-A1 | LIQUID OILY COMPOSITION, AND COSMETIC MATERIAL CONTAINING LIQUID OILY COMPOSITION | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2025-05-29 | — | — | US | claimed |
| WO-2025090562-A1 | FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF | THIRONA BIO, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| US-20250134875-A1 | FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF | THIRONA BIO, INC. (US) | 2025-05-01 | — | — | US | claimed |
| EP-1765260-A2 | SANITIZING COMPOSITION AND METHOD OF PREPARATION | Brown, Steven J. (US) | 2007-03-28 | — | — | EP | claimed |
| US-20060204460-A1 | Lip gloss composition | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2006-09-14 | — | — | US | claimed |
| WO-2006085907-A2 | SANITIZING COMPOSITION AND METHOD OF PREPARATION | BROWN STEVEN J (US) | 2006-08-17 | — | — | WO | claimed |
| US-20060147399-A1 | Non-pressurized post-application expanding composition | CITIBANK, N.A., LONDON BRANCH | 2006-07-06 | — | — | US | claimed |
| WO-2005118759-A1 | COSMECEUTICAL FORMULATION CONTAINING PALM OILS | KOPAS PATRICIA MCKANE (US) | 2005-12-15 | — | — | WO | claimed |
| US-20050271595-A1 | Sanitizing composition and method of preparation | BROWN JAMES S | 2005-12-08 | — | — | US | claimed |
| CN-1703196-A | Non-pressurized post-application expanding compositions | AVON PROD INC (US) | 2005-11-30 | — | — | CN | claimed |
| EP-1575546-A2 | NON-PRESSURIZED POST-APPLICATION EXPANDING COMPOSITION | Avon Products, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| US-20040241254-A1 | Cosmeceutical formulation containing palm oils | PACIFIC SPECIALTY OILS, INC. | 2004-12-02 | — | — | US | claimed |
| WO-2004060292-A2 | NON-PRESSURIZED POST-APPLICATION EXPANDING COMPOSITION | AVON PRODUCTS, INC. (US) | 2004-07-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250134875-A1 | FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF | ALK, ACVR1, ACVRL1 | GPR84 1140/4885FFAR1 854/4885ZDHHC7 3948/4885 |
| US-20250235435-A1 | INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST | PDE12, PDE4A, PDE5A | GPR84 1256/4885FFAR1 341/4885ZDHHC7 3320/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | GPR84 800/4885FFAR1 13/4885ZDHHC7 231/4885 |
| US-20060147399-A1 | Non-pressurized post-application expanding composition | NONO, SMURF1, SMURF2 | GPR84 3047/4885FFAR1 402/4885ZDHHC7 186/4885 |
| US-20040241254-A1 | Cosmeceutical formulation containing palm oils | CUTA, SCD, SCD5 | GPR84 1796/4885FFAR1 605/4885ZDHHC7 503/4885 |
| US-12336983-B2 | Inhibition of crystal growth of roflumilast | PDE12, PDE4A, PDE5A | GPR84 1256/4885FFAR1 341/4885ZDHHC7 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.